Neurology · Akron, OH
Neurology studies in Akron, OH
5 recruiting studies have a site in Akron.
5 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
H. Lundbeck A/S
- Location
- Akron, OH + 13 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
H. Lundbeck A/S
- Location
- Akron, OH + 8 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Xenon Pharmaceuticals Inc.
- Location
- Akron, OH + 44 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Akron, OH + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingHealthy volunteers
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Columbia University
- Location
- Akron, OH + 15 other US sites
- Eligibility basics
- Any age listed
Who these studies look for
Most require a confirmed diagnosis; memory studies often ask for a study partner who knows you well to attend some visits.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.